Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000617205 | SCV000736164 | likely benign | Cardiovascular phenotype | 2017-12-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002491315 | SCV002795468 | likely benign | Progressive familial heart block type IB; Erythrokeratodermia variabilis et progressiva 6 | 2021-09-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005091759 | SCV005812424 | likely benign | Progressive familial heart block type IB | 2024-08-29 | criteria provided, single submitter | clinical testing |